{"id":"https://openalex.org/W3096835610","doi":"https://doi.org/10.1182/blood-2020-137328","title":"Pembrolizumab with R-CHOP in Previously Untreated Diffuse Large B-Cell Lymphoma: Long Term Follow up and Analysis of the Mechanism of Pdl-1 Tumor Expression","display_name":"Pembrolizumab with R-CHOP in Previously Untreated Diffuse Large B-Cell Lymphoma: Long Term Follow up and Analysis of the Mechanism of Pdl-1 Tumor Expression","publication_year":2020,"publication_date":"2020-11-04","ids":{"openalex":"https://openalex.org/W3096835610","doi":"https://doi.org/10.1182/blood-2020-137328","mag":"3096835610"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-137328","doi":"https://doi.org/10.1182/blood-2020-137328","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-137328","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088459737","display_name":"Stephen Douglas Smith","orcid":"https://orcid.org/0000-0001-5354-7593","observed_orcids":["https://orcid.org/0000-0001-5354-7593"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen D. Smith","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA","University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020858509","display_name":"Jonathan R. Fromm","orcid":"https://orcid.org/0000-0002-2287-5284","observed_orcids":["https://orcid.org/0000-0002-2287-5284"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan R. Fromm","raw_affiliation_strings":["Department of Laboratory Medicine, University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045975673","display_name":"Min Fang","orcid":"https://orcid.org/0000-0001-6688-437X","observed_orcids":["https://orcid.org/0000-0001-6688-437X"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Min Fang","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037938194","display_name":"Brian G. Till","orcid":"https://orcid.org/0000-0002-4718-8288","observed_orcids":["https://orcid.org/0000-0002-4718-8288"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian G. Till","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051296565","display_name":"Mazyar S. Shadman","orcid":"https://orcid.org/0000-0002-3365-6562","observed_orcids":["https://orcid.org/0000-0002-3365-6562"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mazyar Shadman","raw_affiliation_strings":["Uw/Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uw/Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005281918","display_name":"Ryan C. Lynch","orcid":"https://orcid.org/0000-0001-6703-0894","observed_orcids":["https://orcid.org/0000-0001-6703-0894"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan C. Lynch","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA","University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024384857","display_name":"Andrew J. Cowan","orcid":"https://orcid.org/0000-0002-1880-7094","observed_orcids":["https://orcid.org/0000-0002-1880-7094","https://orcid.org/0000-0003-2326-2727"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew J. Cowan","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA","Department of Medicine, University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Department of Medicine, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027819567","display_name":"Qian Vicky Wu","orcid":"https://orcid.org/0000-0002-2292-4816","observed_orcids":["https://orcid.org/0000-0002-2292-4816"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qian Vicky Wu","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Department of Clinical Biostatistics, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Department of Clinical Biostatistics, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057524392","display_name":"Jenna M. Voutsinas","orcid":"https://orcid.org/0000-0002-7474-4892","observed_orcids":["https://orcid.org/0000-0002-7474-4892"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jenna Voutsinas","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle,","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Heather A. Rasmussen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather A. Rasmussen","raw_affiliation_strings":["University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055972784","display_name":"Katie Blue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1332479046","display_name":"Seattle Cancer Care Alliance","ror":"https://ror.org/03jq88n71","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1332479046"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katie Blue","raw_affiliation_strings":["University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA","institution_ids":["https://openalex.org/I1332479046","https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079426839","display_name":"Chaitra Shankar Ujjani","orcid":"https://orcid.org/0000-0003-1977-1510","observed_orcids":["https://orcid.org/0000-0003-1977-1510","https://orcid.org/0000-0003-2662-4826"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chaitra S. Ujjani","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA","University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059661907","display_name":"Andrei R. Shustov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrei R Shustov","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA","University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071844603","display_name":"Ryan Daniel Cassaday","orcid":"https://orcid.org/0000-0002-3424-2425","observed_orcids":["https://orcid.org/0000-0002-3424-2425"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan D. Cassaday","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA","Department of Medicine, University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Department of Medicine, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004025497","display_name":"Ajay K. Gopal","orcid":"https://orcid.org/0000-0003-3023-6834","observed_orcids":["https://orcid.org/0000-0003-3023-6834"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajay K. Gopal","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA","University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.483,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.6365433,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"136","issue":"Supplement 1","first_page":"13","last_page":"14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9900000095367432},{"id":"https://openalex.org/keywords/r-chop","display_name":"R-CHOP","score":0.9649999737739563},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9670000076293945},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.6800000071525574},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8479999899864197},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.39500001072883606},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.6869999766349792},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.7889999747276306},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.42899999022483826},{"id":"https://openalex.org/keywords/molecular-karyotyping","display_name":"molecular karyotyping","score":0.5690000057220459},{"id":"https://openalex.org/keywords/previously-untreated-lymphoma","display_name":"previously untreated lymphoma","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.6948426365852356},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6830029487609863},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6820554733276367},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.6519341468811035},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5606823563575745},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.5576225519180298},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.5209704041481018},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5067334771156311},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.48591604828834534},{"id":"https://openalex.org/C2779725641","wikidata":"https://www.wikidata.org/wiki/Q1076228","display_name":"CHOP","level":3,"score":0.4574089050292969},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.453779011964798},{"id":"https://openalex.org/C2777537477","wikidata":"https://www.wikidata.org/wiki/Q17847411","display_name":"BCL6","level":5,"score":0.43395310640335083},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3953756093978882},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3804165720939636},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2848782539367676},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20229771733283997},{"id":"https://openalex.org/C96926380","wikidata":"https://www.wikidata.org/wiki/Q1737968","display_name":"Germinal center","level":4,"score":0.20156541466712952},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.15944170951843262},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.13954058289527893},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.08855068683624268},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.07861831784248352}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-137328","doi":"https://doi.org/10.1182/blood-2020-137328","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-137328","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2921487706","https://openalex.org/W3184587460","https://openalex.org/W2950348075","https://openalex.org/W4387745534","https://openalex.org/W4379282001","https://openalex.org/W2559355069","https://openalex.org/W4200188834","https://openalex.org/W2266227795","https://openalex.org/W3038460779","https://openalex.org/W1454876849"],"abstract_inverted_index":{"Background:":[0],"Rituximab":[1],"with":[2,48,55,134,186,258,290,409,459,482,532,539,569,609],"cyclophosphamide,":[3],"doxorubicin,":[4],"vincristine,":[5],"and":[6,34,81,88,140,251,312,327,346,358,390,394,424,462,480,553,601,723],"prednisone":[7],"(RCHOP)":[8],"remains":[9],"standard":[10,76,190],"therapy":[11,612],"for":[12,147,231,249,432,557,593],"previously":[13,21,135],"untreated":[14,136],"diffuse":[15],"large":[16],"B-cell":[17],"lymphoma":[18,91,139,145,286,293],"(DLBCL).":[19],"We":[20],"reported":[22],"that":[23,60],"adding":[24],"pembrolizumab":[25,173,561],"to":[26,115,182,238,373,418,494,615],"RCHOP":[27,150,183,563],"(PR-CHOP),":[28],"shows":[29],"no":[30,49,194,269,466,582],"significant":[31],"additive":[32],"toxicity":[33],"a":[35,74,236,240,259,288],"promising":[36],"2-year":[37],"progression":[38,50],"free":[39],"survival":[40],"of":[41,65,90,105,123,157,164,224,227,242,263,284,348,364,387,400,404,428,435,478,560,586,595,605,621],"83%":[42,64,311],"(Smith":[43],"B":[44,143],"J":[45],"Haem":[46],"2019),":[47],"events":[51],"among":[52,488],"19":[53],"pts":[54,257,523,531],"known":[56],"PDL-1+":[57,574],"tumors.":[58],"In":[59],"analysis,":[61,318],"we":[62,95],"noted":[63],"patients":[66],"had":[67],"tumor":[68,125,244,320,329,349,535,578],"PDL-1":[69,330,350],"expression":[70,201,331,351,536],"by":[71,235,332,362,366,517],"IHC":[72,333],"using":[73,109,217],"centralized":[75],"assay,":[77],"including":[78],"18/23":[79],"(78%)":[80],"13/23":[82],"(56%)":[83],"demonstrating":[84],"positivity":[85],"in":[86,287,298,470,521,564,573,624,813],"\u22655%":[87],"\u226530%":[89],"cells":[92],"respectively.":[93,402],"Herein":[94],"report":[96],"long-term":[97],"clinical":[98],"follow":[99,261],"up,":[100],"as":[101,103,501],"well":[102],"results":[104,572],"high-resolution":[106],"molecular":[107],"karyotyping":[108],"chromosome":[110,508],"genomic":[111,412,502],"array":[112,413],"testing":[113,414,603],"(CGAT),":[114],"assess":[116,419],"whether":[117],"9p24.1":[118,471,587],"abnormalities":[119],"explained":[120],"the":[121,218,228,276,433,443,558,570,618],"extent":[122],"PDL1":[124,200,534],"expression.":[126],"Methods:":[127],"Pts":[128],"age":[129],"18":[130],"years":[131],"or":[132,162,196,273,324,343,371,437,468,541,584],"older":[133],"DLBCL,":[137],"transformed":[138],"grade":[141],"3":[142,178,342,507],"follicular":[144,285],"eligible":[146],"6-cycle,":[148],"curative-intent":[149],"were":[151,166,233,247,360,384,406,472,588],"eligible.":[152],"Steroids":[153],"within":[154],"7":[155],"days":[156],"treatment,":[158],"active":[159],"autoimmune":[160],"disease,":[161],"history":[163],"pneumonitis":[165],"excluded.":[167],"This":[168,525],"phase":[169],"I":[170],"study":[171,598],"combined":[172],"(200":[174],"mg":[175],"IV":[176],"q":[177],"weeks":[179],"x":[180,184],"6)":[181],"6,":[185],"supportive":[187],"care":[188],"per":[189],"practice.":[191],"There":[192,279],"was":[193,202,207,416,475,519],"maintenance":[195],"consolidation":[197],"therapy.":[198],"Baseline":[199],"analyzed":[203],"centrally":[204],"(Merck/Qualtek).":[205],"CGAT":[206,232],"performed":[208,417],"from":[209,212,397,492],"DNA":[210],"extracted":[211],"formalin-fixed,":[213],"paraffin-embedded":[214],"tissue":[215,229,453],"sections":[216,226],"OncoScan":[219],"platform":[220],"(ThermoFisher).":[221],"H&E":[222],"slides":[223],"adjacent":[225],"used":[230],"evaluated":[234],"pathologist":[237],"ensure":[239],"minimum":[241],"30%":[243],"content.":[245],"Patients":[246],"followed":[248],"relapse":[250,283],"survival.":[252,356],"Results:":[253],"Among":[254],"30":[255],"treated":[256],"median":[260,378],"up":[262],"32":[264],"months,":[265],"there":[266,383,474],"have":[267,550],"been":[268,281,551],"additional":[270,547],"DLBCL":[271,611],"relapses":[272],"deaths":[274],"since":[275],"published":[277],"report.":[278],"has":[280],"one":[282,476],"patient":[289],"initial":[291],"composite":[292],",":[294,714],"who":[295],"is":[296,310,314],"now":[297],"remission":[299],"1":[300,481],"year":[301],"after":[302],"autologous":[303],"stem":[304],"cell":[305,363],"transplantation.":[306],"3-year":[307],"estimated":[308],"PFS":[309,357],"OS":[313,359],"86%.":[315],"On":[316],"univariate":[317],"only":[319],"bulk":[321],"7.5":[322],"cm":[323],"greater":[325,376,514,542],"(p=.02)":[326],"absence":[328,347],"(p=.001)":[334,352],"predicted":[335,353],"inferior":[336],"PFS.":[337],"Tumor":[338],"bulk,":[339],"(p=.03),":[340],"IPI":[341],"higher":[344],"(p=.01),":[345],"worse":[354],"overall":[355],"unaffected":[361],"origin":[365],"IHC,":[367],"double":[368],"expresser":[369],"status,":[370],"diagnosis":[372],"treatment":[374],"interval":[375],"than":[377,515],"(29":[379],"days).":[380],"Regarding":[381],"safety,":[382],"late":[385],"cases":[386,490],"paraneoplastic":[388],"pemphigus":[389],"rheumatoid":[391],"arthritis":[392],"5":[393],"8":[395],"months":[396],"last":[398],"dose":[399],"pembrolizumab,":[401],"Both":[403],"these":[405],"managed":[407],"successfully":[408],"immunosuppression.":[410],"Chromosome":[411],"CGAT)":[415],"copy":[420,425],"number":[421],"aberrations":[422,503],"(CNAs)":[423],"neutral":[426],"loss":[427],"heterozygosity":[429],"(cnLOH),":[430],"particularly":[431],"presence":[434],"gains":[436,583],"amplifications":[438],"involving":[439,504],"locus":[440],"9p24.1,":[441],"containing":[442],"CD274":[444],"(PDL1)":[445],"gene.":[446],"Of":[447],"15":[448],"tested":[449],"pretreatment":[450],"baseline":[451],"diagnostic":[452],"specimens,":[454],"14":[455],"provided":[456],"informative":[457],"result":[458],"12":[460],"abnormal":[461,489],"2":[463],"normal.":[464],"Notably,":[465],"gain":[467],"amplification":[469],"seen;":[473],"case":[477],"deletion":[479],"cnLOH.":[483],"The":[484],"percent":[485],"genome":[486,512],"altered":[487,513],"ranged":[491],"2%":[493],"37%":[495],"(median":[496],"12%).":[497],"Complex":[498],"karyotype,":[499],"defined":[500],"at":[505,580],"least":[506],"arms":[509],"(or":[510],"%":[511],"5%":[516,540],"CGAT),":[518],"seen":[520],"10/14":[522],"(71%).":[524],"14-sample":[526],"data":[527],"set":[528],"included":[529],"6/14":[530],">30%":[533],"(and":[537],"10":[538],"PDL1-tumor":[543],"expression).":[544],"Conclusions:":[545],"No":[546],"safety":[548],"signals":[549],"observed,":[552],"PFS/OS":[554],"remain":[555],"favorable":[556],"combination":[559],"+":[562],"this":[565,599,622,625],"single":[566],"arm":[567],"trial":[568],"best":[571],"disease.":[575],"Despite":[576],"frequent":[577],"PDL1-expression":[579],"baseline,":[581],"implications":[585],"observed":[589],"suggesting":[590],"alternative":[591],"mechanisms":[592],"overexpression":[594],"PDL-1.":[596],"Further":[597],"regimen":[600],"others":[602],"combinations":[604],"immune":[606],"checkpoint":[607],"inhibition":[608],"first-line":[610],"are":[613],"warranted,":[614],"better":[616],"ascertain":[617],"potential":[619],"superiority":[620],"strategy":[623],"setting.":[626],"Disclosures":[627],"Smith:":[628],"Portola:":[629],"Research":[630,633,636,639,642,647,655,662,665,670,673,676,681,684,690,706,728,732,735,739,742,746,751,754,758,763,770,774,791,796,800,804,817,821,825,829,844,869,874],"Funding;":[631,634,637,640,643,648,656,663,666,671,674,677,707,729,733,736,740,743,747,752,759,764,775,792,805,818,822,826,845,870],"Incyte:":[632,734],"Ignyta:":[635],"Genentech:":[638,750,779],"AstraZeneca:":[641,657,793],"Acerta":[644],"Pharma":[645],"BV:":[646],"Karyopharm:":[649],"Consultancy;":[650,652,658,660,749,766,768,783,864],"Beigene:":[651,705],"Seattle":[653,806,846],"Genetics:":[654,799,807],"Millenium/Takeda:":[659],"Pharmacyclics:":[661],"Merck:":[664,816],"De":[667],"Novo":[668],"Biopharma:":[669],"Bayer:":[672],"Ayala:":[675],"Bristol":[678,760],"Meyers":[679],"Squibb:":[680,762],"Funding.":[682,685,691,755,771,797,801,830,875],"Fromm:Merck:":[683],"Till:Mustang:":[686],"Patents":[687],"&":[688],"Royalties,":[689],"Shadman:Mustang":[692],"Bio,":[693],"Celgene,":[694],"Pharmacyclics,":[695,715],"Gilead,":[696],"Genentech,":[697,709],"Abbvie,":[698,708],"TG":[699,737,851,860],"therapeutics,":[700,718,861],"Beigene,":[701,719],"Astra":[702,710,840,853],"Zeneca,":[703,711],"Sunesis,":[704],"Sound":[712],"Biologics":[713],"Verastem,":[716],"ADC":[717,857],"Cellectar,":[720],"BMS,":[721,867],"Morphosys":[722],"Atara":[724],"Biotherapeutics:":[725],"Consultancy.":[726],"Lynch:Bayer:":[727],"Rhizen":[730],"Pharmaceuticals:":[731,803],"Therapeutics:":[738],"Takeda:":[741],"Juno":[744],"Therpeutics:":[745],"MorphoSys:":[748,782],"Cyteir:":[753],"Cowan:Janssen:":[756],"Consultancy,":[757,773,777,780,786,789,794,824,828],"Myers":[761],"Sanofi:":[765],"Cellectar:":[767],"Abbvie:":[769,788],"Ujjani:Gilead/Kite:":[772],"Atara:":[776],"Honoraria;":[778,781,787],"Verastem":[784],"Oncology:":[785],"Honoraria,":[790,795,820],"Shustov:Seattle":[798],"Cassaday:Vanda":[802],"Current":[808,810],"Employment,":[809],"equity":[811],"holder":[812],"publicly-traded":[814],"company;":[815],"Pfizer:":[819],"Amgen:":[823],"Kite/Gilead:":[827],"Gopal:Seattle":[831],"Genetics;":[832,847],"Janssen;":[833,848],"Takeda;":[834],"IgM":[835,865],"Bio;":[836,838,850],"IMab":[837,849],"BMS;":[839],"Zeneca;":[841,854],"Merck;":[842,855],"Gilead:":[843],"Therapeutics;":[852,858],"Gilead;":[856],"Nurix;":[859],"Cellectar;":[862],"Actinium:":[863],"bio,":[866,872],"merck:":[868],"imab":[871],"takeda,astrazeneca,gilead:":[873]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-11-09T00:00:00"}